233 related articles for article (PubMed ID: 2576302)
1. Influence of inducers and inhibitors on the metabolism in vitro and neurochemical effects in vivo of MDMA.
Gollamudi R; Ali SF; Lipe G; Newport G; Webb P; Lopez M; Leakey JE; Kolta M; Slikker W
Neurotoxicology; 1989; 10(3):455-66. PubMed ID: 2576302
[TBL] [Abstract][Full Text] [Related]
2. Stereochemical differences in the metabolism of 3,4-methylenedioxymethamphetamine in vivo and in vitro: a pharmacokinetic analysis.
Cho AK; Hiramatsu M; Distefano EW; Chang AS; Jenden DJ
Drug Metab Dispos; 1990; 18(5):686-91. PubMed ID: 1981721
[TBL] [Abstract][Full Text] [Related]
3. Effects of 3,4-methylenedioxyamphetamine and 3,4-methylenedioxymethamphetamine isomers on central serotonergic, dopaminergic and nigral neurotensin systems of the rat.
Johnson M; Letter AA; Merchant K; Hanson GR; Gibb JW
J Pharmacol Exp Ther; 1988 Mar; 244(3):977-82. PubMed ID: 2472482
[TBL] [Abstract][Full Text] [Related]
4. 3,4-Methylenedioxymethamphetamine and 3,4-methylenedioxyamphetamine destroy serotonin terminals in rat brain: quantification of neurodegeneration by measurement of [3H]paroxetine-labeled serotonin uptake sites.
Battaglia G; Yeh SY; O'Hearn E; Molliver ME; Kuhar MJ; De Souza EB
J Pharmacol Exp Ther; 1987 Sep; 242(3):911-6. PubMed ID: 2443644
[TBL] [Abstract][Full Text] [Related]
5. Metabolism of methylenedioxymethamphetamine: formation of dihydroxymethamphetamine and a quinone identified as its glutathione adduct.
Hiramatsu M; Kumagai Y; Unger SE; Cho AK
J Pharmacol Exp Ther; 1990 Aug; 254(2):521-7. PubMed ID: 1974641
[TBL] [Abstract][Full Text] [Related]
6. Behavioral and neurochemical effects of orally administered MDMA in the rodent and nonhuman primate.
Slikker W; Holson RR; Ali SF; Kolta MG; Paule MG; Scallet AC; McMillan DE; Bailey JR; Hong JS; Scalzo FM
Neurotoxicology; 1989; 10(3):529-42. PubMed ID: 2576304
[TBL] [Abstract][Full Text] [Related]
7. Caffeine promotes hyperthermia and serotonergic loss following co-administration of the substituted amphetamines, MDMA ("Ecstasy") and MDA ("Love").
McNamara R; Kerans A; O'Neill B; Harkin A
Neuropharmacology; 2006 Jan; 50(1):69-80. PubMed ID: 16188283
[TBL] [Abstract][Full Text] [Related]
8. Participation of cytochrome P450-2B and -2D isozymes in the demethylenation of methylenedioxymethamphetamine enantiomers by rats.
Kumagai Y; Lin LY; Hiratsuka A; Narimatsu S; Suzuki T; Yamada H; Oguri K; Yoshimura H; Cho AK
Mol Pharmacol; 1994 Feb; 45(2):359-65. PubMed ID: 7906857
[TBL] [Abstract][Full Text] [Related]
9. Stereochemistry of the metabolism of MDMA to MDA.
Fitzgerald RL; Blanke RV; Rosecrans JA; Glennon RA
Life Sci; 1989; 45(4):295-301. PubMed ID: 2569654
[TBL] [Abstract][Full Text] [Related]
10. Serotonin release contributes to the locomotor stimulant effects of 3,4-methylenedioxymethamphetamine in rats.
Callaway CW; Wing LL; Geyer MA
J Pharmacol Exp Ther; 1990 Aug; 254(2):456-64. PubMed ID: 1974635
[TBL] [Abstract][Full Text] [Related]
11. Metabolism of halazepam by rat liver microsomes: stereoselective formation and N-dealkylation of 3-hydroxyhalazepam.
Lu XL; Yang SK
Chirality; 1990; 2(1):1-9. PubMed ID: 2400636
[TBL] [Abstract][Full Text] [Related]
12. Sprague-Dawley rats display metabolism-mediated sex differences in the acute toxicity of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy).
Fonsart J; Menet MC; Declèves X; Galons H; Crété D; Debray M; Scherrmann JM; Noble F
Toxicol Appl Pharmacol; 2008 Jul; 230(1):117-25. PubMed ID: 18358511
[TBL] [Abstract][Full Text] [Related]
13. Metabolism of prazepam by rat liver microsomes: stereoselective formation and N-dealkylation of 3-hydroxyprazepam.
Lu XL; Yang SK
Mol Pharmacol; 1989 Dec; 36(6):932-8. PubMed ID: 2601688
[TBL] [Abstract][Full Text] [Related]
14. Role of isozymes of cytochrome P-450 in the metabolism of N,N-dimethyl-4-aminoazobenzene in the rat.
Levine WG; Lu AY
Drug Metab Dispos; 1982; 10(2):102-9. PubMed ID: 6124393
[TBL] [Abstract][Full Text] [Related]
15. Spectral and inhibitory interactions of (+/-)-3,4-methylenedioxyamphetamine (MDA) and (+/-)-3,4-methylenedioxymethamphetamine (MDMA) with rat hepatic microsomes.
Brady JF; Di Stefano EW; Cho AK
Life Sci; 1986 Oct; 39(16):1457-64. PubMed ID: 2877380
[TBL] [Abstract][Full Text] [Related]
16. The neurochemical and stimulatory effects of putative metabolites of 3,4-methylenedioxyamphetamine and 3,4-methylenedioxymethamphetamine in rats.
Yeh SY; Hsu FL
Pharmacol Biochem Behav; 1991 Jul; 39(3):787-90. PubMed ID: 1723801
[TBL] [Abstract][Full Text] [Related]
17. Assessment of the role of alpha-methylepinine in the neurotoxicity of MDMA.
Steele TD; Brewster WK; Johnson MP; Nichols DE; Yim GK
Pharmacol Biochem Behav; 1991 Feb; 38(2):345-51. PubMed ID: 1676172
[TBL] [Abstract][Full Text] [Related]
18. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice.
Beland FA
Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702
[TBL] [Abstract][Full Text] [Related]
19. The hyperthermic and neurotoxic effects of 'Ecstasy' (MDMA) and 3,4 methylenedioxyamphetamine (MDA) in the Dark Agouti (DA) rat, a model of the CYP2D6 poor metabolizer phenotype.
Colado MI; Williams JL; Green AR
Br J Pharmacol; 1995 Aug; 115(7):1281-9. PubMed ID: 7582557
[TBL] [Abstract][Full Text] [Related]
20. The role of human hepatic cytochrome P450 isozymes in the metabolism of racemic 3,4-methylenedioxy-methamphetamine and its enantiomers.
Meyer MR; Peters FT; Maurer HH
Drug Metab Dispos; 2008 Nov; 36(11):2345-54. PubMed ID: 18725511
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]